Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:alsoKnownAs |
deudomperidone
|
| gptkbp:clinicalTrialPhase |
Phase 2
|
| gptkbp:deuteratedFormOf |
gptkb:domperidone
|
| gptkbp:developedBy |
gptkb:Sumitomo_Pharma
Shin Nippon Biomedical Laboratories |
| https://www.w3.org/2000/01/rdf-schema#label |
SPT-624
|
| gptkbp:mechanismOfAction |
dopamine D2 receptor antagonist
|
| gptkbp:relatedTo |
gptkb:domperidone
|
| gptkbp:status |
investigational drug
|
| gptkbp:therapeuticArea |
gastrointestinal disorders
|
| gptkbp:bfsParent |
gptkb:SPT_624
|
| gptkbp:bfsLayer |
8
|